Are inflammation-related diseases risk factors for primary acquired nasolacrimal duct obstruction? A large scale, national case-control study

Kerber, Lior
DOI: https://doi.org/10.1007/s00417-023-06352-2
2024-01-10
Graefe s Archive for Clinical and Experimental Ophthalmology
Abstract:To evaluate the incidence and risk factors for inflammatory conditions among patients with primary acquired nasolacrimal duct obstruction (PANDO).
ophthalmology
What problem does this paper attempt to address?